nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorthalidone—CA5B—cervicothoracic ganglion—systemic scleroderma	0.171	0.644	CbGeAlD
Chlorthalidone—CA7—digestive system—systemic scleroderma	0.00863	0.0325	CbGeAlD
Chlorthalidone—CA12—connective tissue—systemic scleroderma	0.00776	0.0292	CbGeAlD
Chlorthalidone—CA9—digestive system—systemic scleroderma	0.00758	0.0285	CbGeAlD
Chlorthalidone—CA9—tendon—systemic scleroderma	0.00721	0.0272	CbGeAlD
Chlorthalidone—SLC12A3—lung—systemic scleroderma	0.00706	0.0266	CbGeAlD
Chlorthalidone—CA12—digestive system—systemic scleroderma	0.00561	0.0211	CbGeAlD
Chlorthalidone—CA5B—tendon—systemic scleroderma	0.00479	0.018	CbGeAlD
Chlorthalidone—CA12—lung—systemic scleroderma	0.00468	0.0176	CbGeAlD
Chlorthalidone—CA1—digestive system—systemic scleroderma	0.00444	0.0167	CbGeAlD
Chlorthalidone—CA5B—lung—systemic scleroderma	0.0042	0.0158	CbGeAlD
Chlorthalidone—CA2—connective tissue—systemic scleroderma	0.00399	0.015	CbGeAlD
Chlorthalidone—CA1—lung—systemic scleroderma	0.00371	0.014	CbGeAlD
Chlorthalidone—CA2—smooth muscle tissue—systemic scleroderma	0.00365	0.0137	CbGeAlD
Chlorthalidone—CA2—skin of body—systemic scleroderma	0.0036	0.0136	CbGeAlD
Chlorthalidone—CA4—digestive system—systemic scleroderma	0.00347	0.0131	CbGeAlD
Chlorthalidone—Diabetes mellitus—Mycophenolic acid—systemic scleroderma	0.00347	0.00472	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Mycophenolate mofetil—systemic scleroderma	0.00334	0.00455	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Lisinopril—systemic scleroderma	0.00333	0.00454	CcSEcCtD
Chlorthalidone—CA4—tendon—systemic scleroderma	0.0033	0.0124	CbGeAlD
Chlorthalidone—Eosinophilia—Captopril—systemic scleroderma	0.00328	0.00447	CcSEcCtD
Chlorthalidone—Pancreatitis—Captopril—systemic scleroderma	0.00325	0.00443	CcSEcCtD
Chlorthalidone—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00313	0.00426	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Lisinopril—systemic scleroderma	0.00312	0.00425	CcSEcCtD
Chlorthalidone—Photosensitivity—Lisinopril—systemic scleroderma	0.00309	0.00421	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00308	0.00419	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Captopril—systemic scleroderma	0.00305	0.00416	CcSEcCtD
Chlorthalidone—Hyponatraemia—Mycophenolic acid—systemic scleroderma	0.00303	0.00412	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Captopril—systemic scleroderma	0.00303	0.00412	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.00302	0.00411	CcSEcCtD
Chlorthalidone—Muscle spasms—Pentoxifylline—systemic scleroderma	0.00293	0.00399	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Mycophenolate mofetil—systemic scleroderma	0.00292	0.00398	CcSEcCtD
Chlorthalidone—CA4—lung—systemic scleroderma	0.0029	0.0109	CbGeAlD
Chlorthalidone—Jaundice—Captopril—systemic scleroderma	0.00288	0.00392	CcSEcCtD
Chlorthalidone—CA2—digestive system—systemic scleroderma	0.00288	0.0108	CbGeAlD
Chlorthalidone—Hypokalaemia—Leflunomide—systemic scleroderma	0.00288	0.00392	CcSEcCtD
Chlorthalidone—Cramp muscle—Leflunomide—systemic scleroderma	0.00285	0.00388	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.00285	0.00388	CcSEcCtD
Chlorthalidone—Pancreatitis—Azathioprine—systemic scleroderma	0.00284	0.00386	CcSEcCtD
Chlorthalidone—Agitation—Pentoxifylline—systemic scleroderma	0.0028	0.00382	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00277	0.00378	CcSEcCtD
Chlorthalidone—Agranulocytosis—Captopril—systemic scleroderma	0.00276	0.00376	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00276	0.00375	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.00276	0.00375	CcSEcCtD
Chlorthalidone—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.00275	0.00374	CcSEcCtD
Chlorthalidone—Glycosuria—Prednisone—systemic scleroderma	0.00274	0.00374	CcSEcCtD
Chlorthalidone—CA2—tendon—systemic scleroderma	0.00274	0.0103	CbGeAlD
Chlorthalidone—Diabetes mellitus—Mycophenolate mofetil—systemic scleroderma	0.00274	0.00373	CcSEcCtD
Chlorthalidone—Leukopenia—Pentoxifylline—systemic scleroderma	0.00273	0.00372	CcSEcCtD
Chlorthalidone—Hyponatraemia—Lisinopril—systemic scleroderma	0.00273	0.00372	CcSEcCtD
Chlorthalidone—Cramp muscle—Mycophenolic acid—systemic scleroderma	0.00272	0.0037	CcSEcCtD
Chlorthalidone—Eosinophilia—Leflunomide—systemic scleroderma	0.00271	0.00369	CcSEcCtD
Chlorthalidone—Pancreatitis—Leflunomide—systemic scleroderma	0.00268	0.00365	CcSEcCtD
Chlorthalidone—Pancreatitis—Mycophenolic acid—systemic scleroderma	0.00256	0.00348	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00248	0.00338	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00247	0.00336	CcSEcCtD
Chlorthalidone—Cramp muscle—Lisinopril—systemic scleroderma	0.00245	0.00333	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.00245	0.00333	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00244	0.00332	CcSEcCtD
Chlorthalidone—Agranulocytosis—Azathioprine—systemic scleroderma	0.00241	0.00328	CcSEcCtD
Chlorthalidone—CA2—lung—systemic scleroderma	0.0024	0.00905	CbGeAlD
Chlorthalidone—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.0024	0.00327	CcSEcCtD
Chlorthalidone—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.00239	0.00326	CcSEcCtD
Chlorthalidone—Jaundice—Leflunomide—systemic scleroderma	0.00238	0.00323	CcSEcCtD
Chlorthalidone—Anorexia—Pentoxifylline—systemic scleroderma	0.00237	0.00323	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00235	0.0032	CcSEcCtD
Chlorthalidone—Eosinophilia—Lisinopril—systemic scleroderma	0.00233	0.00317	CcSEcCtD
Chlorthalidone—Pancreatitis—Lisinopril—systemic scleroderma	0.0023	0.00314	CcSEcCtD
Chlorthalidone—Vasculitis—Prednisone—systemic scleroderma	0.00228	0.0031	CcSEcCtD
Chlorthalidone—Agranulocytosis—Leflunomide—systemic scleroderma	0.00227	0.0031	CcSEcCtD
Chlorthalidone—Jaundice—Mycophenolic acid—systemic scleroderma	0.00227	0.00309	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00217	0.00296	CcSEcCtD
Chlorthalidone—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00217	0.00295	CcSEcCtD
Chlorthalidone—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00217	0.00295	CcSEcCtD
Chlorthalidone—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00216	0.00295	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00216	0.00295	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00214	0.00292	CcSEcCtD
Chlorthalidone—Constipation—Pentoxifylline—systemic scleroderma	0.00213	0.0029	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00212	0.00288	CcSEcCtD
Chlorthalidone—Arrhythmia—Azathioprine—systemic scleroderma	0.00207	0.00282	CcSEcCtD
Chlorthalidone—Anorexia—Mometasone—systemic scleroderma	0.00205	0.00279	CcSEcCtD
Chlorthalidone—Jaundice—Lisinopril—systemic scleroderma	0.00204	0.00278	CcSEcCtD
Chlorthalidone—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00202	0.00275	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Methotrexate—systemic scleroderma	0.002	0.00273	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Prednisone—systemic scleroderma	0.00198	0.00269	CcSEcCtD
Chlorthalidone—Urticaria—Pentoxifylline—systemic scleroderma	0.00198	0.00269	CcSEcCtD
Chlorthalidone—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00197	0.00268	CcSEcCtD
Chlorthalidone—Arrhythmia—Leflunomide—systemic scleroderma	0.00195	0.00266	CcSEcCtD
Chlorthalidone—Agranulocytosis—Lisinopril—systemic scleroderma	0.00195	0.00266	CcSEcCtD
Chlorthalidone—Paraesthesia—Mometasone—systemic scleroderma	0.00193	0.00263	CcSEcCtD
Chlorthalidone—Vasculitis—Methotrexate—systemic scleroderma	0.0019	0.00259	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.0019	0.00258	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Methotrexate—systemic scleroderma	0.00189	0.00258	CcSEcCtD
Chlorthalidone—Decreased appetite—Mometasone—systemic scleroderma	0.00187	0.00254	CcSEcCtD
Chlorthalidone—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00186	0.00254	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00253	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Prednisone—systemic scleroderma	0.00186	0.00253	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Captopril—systemic scleroderma	0.00185	0.00251	CcSEcCtD
Chlorthalidone—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00183	0.0025	CcSEcCtD
Chlorthalidone—Muscle spasms—Leflunomide—systemic scleroderma	0.00183	0.00249	CcSEcCtD
Chlorthalidone—Leukopenia—Azathioprine—systemic scleroderma	0.00181	0.00246	CcSEcCtD
Chlorthalidone—Vascular purpura—Prednisone—systemic scleroderma	0.0018	0.00246	CcSEcCtD
Chlorthalidone—Anorexia—Captopril—systemic scleroderma	0.0018	0.00245	CcSEcCtD
Chlorthalidone—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00244	CcSEcCtD
Chlorthalidone—Asthenia—Pentoxifylline—systemic scleroderma	0.00179	0.00243	CcSEcCtD
Chlorthalidone—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00175	0.00238	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00174	0.00238	CcSEcCtD
Chlorthalidone—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00233	CcSEcCtD
Chlorthalidone—Vertigo—Leflunomide—systemic scleroderma	0.00171	0.00233	CcSEcCtD
Chlorthalidone—Leukopenia—Leflunomide—systemic scleroderma	0.0017	0.00232	CcSEcCtD
Chlorthalidone—Diarrhoea—Pentoxifylline—systemic scleroderma	0.0017	0.00232	CcSEcCtD
Chlorthalidone—Abdominal pain—Mometasone—systemic scleroderma	0.0017	0.00231	CcSEcCtD
Chlorthalidone—Paraesthesia—Captopril—systemic scleroderma	0.00169	0.00231	CcSEcCtD
Chlorthalidone—Arrhythmia—Lisinopril—systemic scleroderma	0.00168	0.00229	CcSEcCtD
Chlorthalidone—Purpura—Prednisone—systemic scleroderma	0.00167	0.00228	CcSEcCtD
Chlorthalidone—Agitation—Mycophenolic acid—systemic scleroderma	0.00167	0.00227	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00165	0.00225	CcSEcCtD
Chlorthalidone—Dizziness—Pentoxifylline—systemic scleroderma	0.00165	0.00224	CcSEcCtD
Chlorthalidone—Decreased appetite—Captopril—systemic scleroderma	0.00164	0.00223	CcSEcCtD
Chlorthalidone—Vertigo—Mycophenolic acid—systemic scleroderma	0.00163	0.00222	CcSEcCtD
Chlorthalidone—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00163	0.00221	CcSEcCtD
Chlorthalidone—Constipation—Captopril—systemic scleroderma	0.00161	0.0022	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00161	0.00219	CcSEcCtD
Chlorthalidone—Vomiting—Pentoxifylline—systemic scleroderma	0.00158	0.00215	CcSEcCtD
Chlorthalidone—Muscle spasms—Lisinopril—systemic scleroderma	0.00157	0.00214	CcSEcCtD
Chlorthalidone—Rash—Pentoxifylline—systemic scleroderma	0.00157	0.00214	CcSEcCtD
Chlorthalidone—Dermatitis—Pentoxifylline—systemic scleroderma	0.00157	0.00213	CcSEcCtD
Chlorthalidone—Headache—Pentoxifylline—systemic scleroderma	0.00156	0.00212	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Methotrexate—systemic scleroderma	0.00155	0.00211	CcSEcCtD
Chlorthalidone—Asthenia—Mometasone—systemic scleroderma	0.00154	0.0021	CcSEcCtD
Chlorthalidone—Photosensitivity—Methotrexate—systemic scleroderma	0.00154	0.00209	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00152	0.00207	CcSEcCtD
Chlorthalidone—Abdominal pain—Captopril—systemic scleroderma	0.00149	0.00203	CcSEcCtD
Chlorthalidone—Anorexia—Leflunomide—systemic scleroderma	0.00148	0.00202	CcSEcCtD
Chlorthalidone—Nausea—Pentoxifylline—systemic scleroderma	0.00148	0.00201	CcSEcCtD
Chlorthalidone—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00147	0.002	CcSEcCtD
Chlorthalidone—Vertigo—Lisinopril—systemic scleroderma	0.00147	0.002	CcSEcCtD
Chlorthalidone—Diarrhoea—Mometasone—systemic scleroderma	0.00147	0.002	CcSEcCtD
Chlorthalidone—Hypokalaemia—Prednisone—systemic scleroderma	0.00147	0.002	CcSEcCtD
Chlorthalidone—Leukopenia—Lisinopril—systemic scleroderma	0.00146	0.00199	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00145	0.00198	CcSEcCtD
Chlorthalidone—Anorexia—Mycophenolic acid—systemic scleroderma	0.00141	0.00192	CcSEcCtD
Chlorthalidone—Paraesthesia—Leflunomide—systemic scleroderma	0.0014	0.0019	CcSEcCtD
Chlorthalidone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00188	CcSEcCtD
Chlorthalidone—Pancreatitis—Prednisone—systemic scleroderma	0.00137	0.00186	CcSEcCtD
Chlorthalidone—Vomiting—Mometasone—systemic scleroderma	0.00137	0.00186	CcSEcCtD
Chlorthalidone—Rash—Mometasone—systemic scleroderma	0.00135	0.00184	CcSEcCtD
Chlorthalidone—Asthenia—Captopril—systemic scleroderma	0.00135	0.00184	CcSEcCtD
Chlorthalidone—Dermatitis—Mometasone—systemic scleroderma	0.00135	0.00184	CcSEcCtD
Chlorthalidone—Decreased appetite—Leflunomide—systemic scleroderma	0.00135	0.00184	CcSEcCtD
Chlorthalidone—Headache—Mometasone—systemic scleroderma	0.00135	0.00183	CcSEcCtD
Chlorthalidone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00133	0.00181	CcSEcCtD
Chlorthalidone—Constipation—Leflunomide—systemic scleroderma	0.00133	0.00181	CcSEcCtD
Chlorthalidone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00179	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00131	0.00178	CcSEcCtD
Chlorthalidone—Abdominal pain—Azathioprine—systemic scleroderma	0.0013	0.00177	CcSEcCtD
Chlorthalidone—Diarrhoea—Captopril—systemic scleroderma	0.00129	0.00176	CcSEcCtD
Chlorthalidone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00129	0.00176	CcSEcCtD
Chlorthalidone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00175	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Prednisone—systemic scleroderma	0.00128	0.00175	CcSEcCtD
Chlorthalidone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00175	CcSEcCtD
Chlorthalidone—Nausea—Mometasone—systemic scleroderma	0.00128	0.00174	CcSEcCtD
Chlorthalidone—Anorexia—Lisinopril—systemic scleroderma	0.00127	0.00173	CcSEcCtD
Chlorthalidone—Constipation—Mycophenolic acid—systemic scleroderma	0.00127	0.00173	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Prednisone—systemic scleroderma	0.00126	0.00171	CcSEcCtD
Chlorthalidone—Dizziness—Captopril—systemic scleroderma	0.00125	0.0017	CcSEcCtD
Chlorthalidone—Urticaria—Leflunomide—systemic scleroderma	0.00123	0.00168	CcSEcCtD
Chlorthalidone—Abdominal pain—Leflunomide—systemic scleroderma	0.00123	0.00167	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00121	0.00165	CcSEcCtD
Chlorthalidone—Hypersensitivity—Azathioprine—systemic scleroderma	0.00121	0.00165	CcSEcCtD
Chlorthalidone—Paraesthesia—Lisinopril—systemic scleroderma	0.0012	0.00163	CcSEcCtD
Chlorthalidone—Vomiting—Captopril—systemic scleroderma	0.0012	0.00163	CcSEcCtD
Chlorthalidone—Rash—Captopril—systemic scleroderma	0.00119	0.00162	CcSEcCtD
Chlorthalidone—Dermatitis—Captopril—systemic scleroderma	0.00119	0.00162	CcSEcCtD
Chlorthalidone—Headache—Captopril—systemic scleroderma	0.00118	0.00161	CcSEcCtD
Chlorthalidone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00117	0.0016	CcSEcCtD
Chlorthalidone—Decreased appetite—Lisinopril—systemic scleroderma	0.00116	0.00158	CcSEcCtD
Chlorthalidone—Eosinophilia—Methotrexate—systemic scleroderma	0.00115	0.00157	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00156	CcSEcCtD
Chlorthalidone—Hypersensitivity—Leflunomide—systemic scleroderma	0.00115	0.00156	CcSEcCtD
Chlorthalidone—Pancreatitis—Methotrexate—systemic scleroderma	0.00114	0.00156	CcSEcCtD
Chlorthalidone—Constipation—Lisinopril—systemic scleroderma	0.00114	0.00156	CcSEcCtD
Chlorthalidone—Diarrhoea—Azathioprine—systemic scleroderma	0.00113	0.00153	CcSEcCtD
Chlorthalidone—Nausea—Captopril—systemic scleroderma	0.00112	0.00153	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00112	0.00152	CcSEcCtD
Chlorthalidone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00152	CcSEcCtD
Chlorthalidone—Asthenia—Leflunomide—systemic scleroderma	0.00112	0.00152	CcSEcCtD
Chlorthalidone—Dizziness—Azathioprine—systemic scleroderma	0.00109	0.00148	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00107	0.00146	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00106	0.00145	CcSEcCtD
Chlorthalidone—Asthenia—Mycophenolic acid—systemic scleroderma	0.00106	0.00145	CcSEcCtD
Chlorthalidone—Diarrhoea—Leflunomide—systemic scleroderma	0.00106	0.00145	CcSEcCtD
Chlorthalidone—Urticaria—Lisinopril—systemic scleroderma	0.00106	0.00144	CcSEcCtD
Chlorthalidone—Abdominal pain—Lisinopril—systemic scleroderma	0.00106	0.00144	CcSEcCtD
Chlorthalidone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00143	CcSEcCtD
Chlorthalidone—Vomiting—Azathioprine—systemic scleroderma	0.00105	0.00143	CcSEcCtD
Chlorthalidone—Rash—Azathioprine—systemic scleroderma	0.00104	0.00141	CcSEcCtD
Chlorthalidone—Dermatitis—Azathioprine—systemic scleroderma	0.00104	0.00141	CcSEcCtD
Chlorthalidone—Headache—Azathioprine—systemic scleroderma	0.00103	0.0014	CcSEcCtD
Chlorthalidone—Dizziness—Leflunomide—systemic scleroderma	0.00103	0.0014	CcSEcCtD
Chlorthalidone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00139	CcSEcCtD
Chlorthalidone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00101	0.00138	CcSEcCtD
Chlorthalidone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.001	0.00136	CcSEcCtD
Chlorthalidone—Arrhythmia—Prednisone—systemic scleroderma	0.000997	0.00136	CcSEcCtD
Chlorthalidone—Vomiting—Leflunomide—systemic scleroderma	0.000988	0.00135	CcSEcCtD
Chlorthalidone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000984	0.00134	CcSEcCtD
Chlorthalidone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000981	0.00134	CcSEcCtD
Chlorthalidone—Rash—Leflunomide—systemic scleroderma	0.00098	0.00133	CcSEcCtD
Chlorthalidone—Dermatitis—Leflunomide—systemic scleroderma	0.000979	0.00133	CcSEcCtD
Chlorthalidone—Nausea—Azathioprine—systemic scleroderma	0.000978	0.00133	CcSEcCtD
Chlorthalidone—Headache—Leflunomide—systemic scleroderma	0.000974	0.00133	CcSEcCtD
Chlorthalidone—Agranulocytosis—Methotrexate—systemic scleroderma	0.00097	0.00132	CcSEcCtD
Chlorthalidone—Asthenia—Lisinopril—systemic scleroderma	0.000958	0.0013	CcSEcCtD
Chlorthalidone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000943	0.00128	CcSEcCtD
Chlorthalidone—Rash—Mycophenolic acid—systemic scleroderma	0.000935	0.00127	CcSEcCtD
Chlorthalidone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000934	0.00127	CcSEcCtD
Chlorthalidone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00093	0.00127	CcSEcCtD
Chlorthalidone—Headache—Mycophenolic acid—systemic scleroderma	0.000929	0.00126	CcSEcCtD
Chlorthalidone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000925	0.00126	CcSEcCtD
Chlorthalidone—Nausea—Leflunomide—systemic scleroderma	0.000923	0.00126	CcSEcCtD
Chlorthalidone—Diarrhoea—Lisinopril—systemic scleroderma	0.000914	0.00124	CcSEcCtD
Chlorthalidone—Agitation—Prednisone—systemic scleroderma	0.000893	0.00122	CcSEcCtD
Chlorthalidone—Dizziness—Lisinopril—systemic scleroderma	0.000883	0.0012	CcSEcCtD
Chlorthalidone—Nausea—Mycophenolic acid—systemic scleroderma	0.000881	0.0012	CcSEcCtD
Chlorthalidone—Vertigo—Prednisone—systemic scleroderma	0.000873	0.00119	CcSEcCtD
Chlorthalidone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000862	0.00117	CcSEcCtD
Chlorthalidone—Vomiting—Lisinopril—systemic scleroderma	0.000849	0.00116	CcSEcCtD
Chlorthalidone—Rash—Lisinopril—systemic scleroderma	0.000842	0.00115	CcSEcCtD
Chlorthalidone—Dermatitis—Lisinopril—systemic scleroderma	0.000841	0.00115	CcSEcCtD
Chlorthalidone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00084	0.00114	CcSEcCtD
Chlorthalidone—Headache—Lisinopril—systemic scleroderma	0.000837	0.00114	CcSEcCtD
Chlorthalidone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000801	0.00109	CcSEcCtD
Chlorthalidone—Nausea—Lisinopril—systemic scleroderma	0.000793	0.00108	CcSEcCtD
Chlorthalidone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000774	0.00105	CcSEcCtD
Chlorthalidone—Anorexia—Prednisone—systemic scleroderma	0.000756	0.00103	CcSEcCtD
Chlorthalidone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000744	0.00101	CcSEcCtD
Chlorthalidone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000738	0.001	CcSEcCtD
Chlorthalidone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000737	0.001	CcSEcCtD
Chlorthalidone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000733	0.000998	CcSEcCtD
Chlorthalidone—Vertigo—Methotrexate—systemic scleroderma	0.00073	0.000994	CcSEcCtD
Chlorthalidone—Leukopenia—Methotrexate—systemic scleroderma	0.000727	0.00099	CcSEcCtD
Chlorthalidone—Paraesthesia—Prednisone—systemic scleroderma	0.000712	0.00097	CcSEcCtD
Chlorthalidone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000695	0.000947	CcSEcCtD
Chlorthalidone—Decreased appetite—Prednisone—systemic scleroderma	0.00069	0.000939	CcSEcCtD
Chlorthalidone—Constipation—Prednisone—systemic scleroderma	0.000678	0.000924	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000649	0.000884	CcSEcCtD
Chlorthalidone—Anorexia—Methotrexate—systemic scleroderma	0.000632	0.00086	CcSEcCtD
Chlorthalidone—Urticaria—Prednisone—systemic scleroderma	0.00063	0.000858	CcSEcCtD
Chlorthalidone—Abdominal pain—Prednisone—systemic scleroderma	0.000627	0.000854	CcSEcCtD
Chlorthalidone—Paraesthesia—Methotrexate—systemic scleroderma	0.000595	0.000811	CcSEcCtD
Chlorthalidone—Hypersensitivity—Prednisone—systemic scleroderma	0.000584	0.000796	CcSEcCtD
Chlorthalidone—Decreased appetite—Methotrexate—systemic scleroderma	0.000576	0.000785	CcSEcCtD
Chlorthalidone—Asthenia—Prednisone—systemic scleroderma	0.000569	0.000775	CcSEcCtD
Chlorthalidone—Diarrhoea—Prednisone—systemic scleroderma	0.000543	0.000739	CcSEcCtD
Chlorthalidone—Urticaria—Methotrexate—systemic scleroderma	0.000527	0.000717	CcSEcCtD
Chlorthalidone—Dizziness—Prednisone—systemic scleroderma	0.000525	0.000714	CcSEcCtD
Chlorthalidone—Abdominal pain—Methotrexate—systemic scleroderma	0.000524	0.000714	CcSEcCtD
Chlorthalidone—Vomiting—Prednisone—systemic scleroderma	0.000504	0.000687	CcSEcCtD
Chlorthalidone—Rash—Prednisone—systemic scleroderma	0.0005	0.000681	CcSEcCtD
Chlorthalidone—Dermatitis—Prednisone—systemic scleroderma	0.0005	0.00068	CcSEcCtD
Chlorthalidone—Headache—Prednisone—systemic scleroderma	0.000497	0.000677	CcSEcCtD
Chlorthalidone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000488	0.000665	CcSEcCtD
Chlorthalidone—Asthenia—Methotrexate—systemic scleroderma	0.000476	0.000648	CcSEcCtD
Chlorthalidone—Nausea—Prednisone—systemic scleroderma	0.000471	0.000642	CcSEcCtD
Chlorthalidone—Diarrhoea—Methotrexate—systemic scleroderma	0.000454	0.000618	CcSEcCtD
Chlorthalidone—Dizziness—Methotrexate—systemic scleroderma	0.000438	0.000597	CcSEcCtD
Chlorthalidone—Vomiting—Methotrexate—systemic scleroderma	0.000422	0.000574	CcSEcCtD
Chlorthalidone—Rash—Methotrexate—systemic scleroderma	0.000418	0.000569	CcSEcCtD
Chlorthalidone—Dermatitis—Methotrexate—systemic scleroderma	0.000418	0.000569	CcSEcCtD
Chlorthalidone—Headache—Methotrexate—systemic scleroderma	0.000415	0.000566	CcSEcCtD
Chlorthalidone—Nausea—Methotrexate—systemic scleroderma	0.000394	0.000536	CcSEcCtD
